Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

A subgroup analysis of the HOST-IDEA randomized controlled trial showed efficacy differences of Ultrathin Strut DES

News | Stents Drug Eluting

Late-Breaking Study Data: BIOTRONIK’s Orsiro DES Outperforms Other Ultrathin Strut Drug-Eluting Stent

July 12, 2023 — In a late breaking trial session during EuroPCR 2023 in Paris, on behalf of the HOST-IDEA study ...

July 12, 2023

US study seeking to confirm strong efficacy data reported in RED DESERT and SAHARA

News | Heart Failure

Sequana Medical Announces First Patient Enrolled in MOJAVE

July 10, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

July 10, 2023

Coronary computed tomography angiography is a cheaper, less-invasive alternative to intravascular ultrasound in pharmaceutical clinical trials

Feature | Cardiac Imaging | By Matthew Jay Budoff, MD, FACC, FAHA

The Benefits of Coronary CTA in Pharmaceutical Clinical Trials

Coronary computed tomography angiography (CCTA) is cheaper, easier to use and its results are easier to understand than ...

July 10, 2023

Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs when the heart beats so fast that the upper chambers of the heart quiver. This irregular heartbeat can lead to severe conditions, including heart failure, dementia and a fivefold increase in the risk of stroke

News | Atrial Fibrillation

Reduced Levels of FKBP5 Promote Atrial Fibrillation

July 7, 2023 — Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs ...

July 07, 2023

UM School of Medicine faculty develop tool to assess risks earlier in vulnerable patients

News | Cardiovascular Clinical Studies

New Study Highlights Dangers of Cumulative Exposure to Cardiovascular Risks and Need for Earlier Primary Prevention Strategies

July 5, 2023 — With heart disease the most common cause of death worldwide, researchers have attempted to quantify how ...

July 05, 2023

Preferential use of pulmonary MR angiography (MRA) for diagnosing pulmonary embolus (PE) in the general population helped conserve iodinated contrast media during the 2022 shortage

News | Contrast Media

Switch to MR Angiography for PE Mitigated Impact of Recent Contrast Shortage

July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

July 03, 2023

UNC School of Medicine scientists Whitney Edwards, Ph.D., Frank Conlon, Ph.D., and colleagues identified molecular pathways critical for heart development.

News | Congenital Heart

Researchers Target Proteins, Pathways Behind Congenital Heart Disease

July 3, 2023 — Researchers at the UNC School of Medicine, UNC McAllister Heart Institute, and the UNC Lineberger ...

July 03, 2023

Approval based on two positive Phase 3 trials, EXPLORER-HCM and VALOR-HCM, demonstrating significant benefit in patients treated with CAMZYOS versus placebo

News | Pharmaceuticals

Bristol Myers Squibb Receives European Commission Approval of CAMZYOS (mavacamten), for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM)

June 28, 2023 — Bristol Myers Squibb announced that the European Commission (EC) has approved CAMZYOS (mavacamten, 2.5 ...

June 28, 2023

Global clinical study aims to broaden evidence base by assessing clinical and economic benefits for the FFRangio System

News | FFR Technologies

CathWorks Announces First Patient Enrolled in Global ALL-RISE Study

June 28, 2023 — CathWorks announced that the first patient has been enrolled in the Advancing Cath Lab Results with FFRa ...

June 28, 2023

This study aimed to evaluate the association between LDL-C levels, post-stroke infection and all-cause mortality. 804,855 ischemic stroke patients were enrolled.

News | Stroke

U-shaped Association Between Low-density Lipoprotein Cholesterol Levels and Risk of All-cause Mortality Mediated by Post-stroke Infection in Acute Ischemic Stroke

June 28, 2023 — The general perception supports the mantra of “lower is better” for low-density lipoprotein cholesterol ...

June 28, 2023

Ground-breaking new Perspectum research using Magnetic Resonance Imaging (MRI) AI-enabled assessment tools has revealed that patients with liver disease are at considerably higher risk of heart failure and other serious heart-related problems.

News | Magnetic Resonance Imaging (MRI)

New Study Uncovers Unprecedented Links Between Liver and Heart Health and the Importance of Doctors' Prioritizing Liver Health to Promote Heart Health

June 28, 2023 — Liver disease, the UK’s third leading cause of premature death, poses a significantly greater threat to ...

June 28, 2023

Day-long summit organized by CRF and Fogarty Innovation will convene clinicians, entrepreneurs, industry, and government stakeholders for education, collaboration, and real-world insight

News | Stents Carotid

InspireMD Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial

June 26, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of str ...

June 26, 2023

Randomized clinical trial enrolled patients with acute chest pain, mildly elevated troponin

News | Cardiovascular Clinical Studies

Less-invasive Cardiac MRI Is a Valuable Diagnostic Tool in the Early Evaluation of Patients with Acute Chest Pain

June 22, 2023 — An estimated 3 million patients visit emergency departments each year with acute chest pain and mildly ...

June 22, 2023

The Society of Interventional Radiology (SIR) published a new position statement offering recommendations on the management of chronic iliofemoral venous obstruction with endovascular placement of metallic stents.

News | Interventional Radiology

Newly Published Society of Interventional Radiology Position Statement Outlines Appropriate Use of Endovascular Management for Treatment of Chronic Iliofemoral Venous Occlusions

June 22, 2023 — The Society of Interventional Radiology (SIR) published a new position statement offering ...

June 22, 2023

Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the DETOUR System to treat patients with complex peripheral arterial disease (PAD).

News | Peripheral Artery Disease (PAD)

Endologix Announces 24-Month Results of DETOUR- 2 Study at 2023 Vascular Annual Meeting

June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive ...

June 16, 2023